Digestive & Intestinal Remedies (Pharmacies) - South America

  • South America
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$1.36bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.94%, resulting in a market volume of US$1.65bn by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$3.30 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in South America is experiencing significant growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences:
Customers in South America are increasingly seeking digestive and intestinal remedies from pharmacies due to a growing awareness of the importance of digestive health. They are looking for over-the-counter remedies that can provide quick relief from common digestive issues such as indigestion, bloating, and heartburn. Additionally, customers are becoming more conscious of the ingredients used in these remedies and are opting for natural and herbal products that are perceived to be safer and have fewer side effects.

Trends in the market:
One of the key trends in the Digestive & Intestinal Remedies market in South America is the rising demand for probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They help in maintaining a healthy balance of gut bacteria and can alleviate symptoms of digestive disorders. The increasing popularity of probiotics can be attributed to the growing awareness of their benefits among customers and the availability of a wide range of probiotic products in pharmacies. Another trend in the market is the growing preference for digestive remedies with added functional ingredients. Customers are looking for products that not only provide relief from digestive issues but also offer additional health benefits. For example, digestive remedies with added fiber or antioxidants are gaining popularity as they help in improving overall digestive health and boosting the immune system.

Local special circumstances:
South America has a rich cultural heritage of natural remedies and traditional medicine. This has influenced the local preferences for digestive and intestinal remedies. Customers in South America have a preference for natural and herbal remedies that are derived from traditional ingredients and have been used for centuries to treat digestive issues. This preference for natural remedies has led to the growth of local brands that specialize in herbal digestive remedies.

Underlying macroeconomic factors:
The growing middle-class population in South America is a major driver of the Digestive & Intestinal Remedies market. As disposable incomes rise, more people are able to afford over-the-counter remedies for their digestive issues. Additionally, the increasing urbanization and hectic lifestyles in the region have led to a rise in stress levels and unhealthy eating habits, which contribute to digestive problems. This has further fueled the demand for digestive and intestinal remedies in South America. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in South America is witnessing growth due to changing customer preferences, emerging trends such as the demand for probiotics and functional ingredients, local special circumstances that favor natural and herbal remedies, and underlying macroeconomic factors such as the growing middle-class population and urbanization. The market is expected to continue growing as customers become more aware of the importance of digestive health and seek effective remedies for their digestive issues.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)